Serdexmethylphenidate/dexmethylphenidate, sold under the brand name Azstarys, is a fixed-dose combination medication containing serdexmethylphenidate and dexmethylphenidate which is used to treat attention deficit hyperactivity disorder (ADHD) in people aged six years and older. It was approved for medical use in the United States in March 2021.
Attributes | Values |
---|---|
rdf:type | |
rdfs:label |
|
rdfs:comment |
|
differentFrom | |
foaf:depiction | |
dcterms:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage | |
Link from a Wikipage to an external page | |
sameAs | |
dbp:wikiPageUsesTemplate | |
thumbnail | |
ATC prefix |
|
class |
|
component |
|
image |
|
KEGG |
|
legal US |
|
routes of administration | |
synonyms |
|
tradename |
|
type |
|
width |
|
has abstract |
|
DailyMedID |
|
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
alternative name |
|
KEGG |
|
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of | |
is Wikipage redirect of | |
is foaf:primaryTopic of |